{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:06:05Z","timestamp":1790193965657,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Danube University Krems University for Continuing Education"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Colorectal cancer is the fourth most common cancer in Austria. To date, colorectal cancer screening in Austria remains opportunistic and includes colonoscopy or stool-based blood tests. The Austrian National Committee for Cancer Screening developed evidence-based recommendations for a\u00a0nationwide organized colorectal cancer screening program.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The methodological framework followed the approach of the United States Preventive Services Task Force. The evidence base underlying the newly developed recommendations comprised a\u00a0review of the existing published evidence and a\u00a0decision analytic model tailored to the Austrian context. Using a\u00a0structured process, committee members considered 1)\u00a0the magnitude of the net benefit of each screening strategy, 2)\u00a0the certainty of evidence, and 3)\u00a0the level of acceptance of the interventions among the target population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recommendations<\/jats:title>\n                <jats:p>The Austrian National Committee for Cancer Screening recommends the implementation of a\u00a0nationwide organized colorectal cancer screening program for all adults aged 45\u201375\u00a0years. For persons 65\u00a0years or older, screening decisions should occur on an individual basis in accordance with a\u00a0person\u2019s overall health, prior screening history, and preferences.<\/jats:p>\n                <jats:p>Specifically, the committee recommends either a\u00a010-year screening colonoscopy or biennial fecal immunochemical tests with colonoscopy following a\u00a0positive result, with both screening strategies considered equivalent. Each citizen should be able to make an informed decision about their preferred screening method. Switching between the two screening strategies should be possible. Following an unremarkable colonoscopy, screening by fecal immunochemical test (FIT) is only required after 10\u00a0years. Screening recommendations apply only to asymptomatic persons at average risk for colorectal cancer.<\/jats:p>\n                <jats:p>The screening program must be pilot tested, and accompanied by a\u00a0public information campaign, formative evaluation, quality assurance, and data collection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00508-023-02209-0","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T14:02:33Z","timestamp":1685541753000},"page":"447-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Screening for colorectal cancer"],"prefix":"10.1007","volume":"135","author":[{"given":"Gerald","family":"Gartlehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schernhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd F.","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Bachler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Titzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kletecka-Pulker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Turnher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"2209_CR1","unstructured":"Statistik Austria. Krebserkrankungen. https:\/\/www.statistik.at\/statistiken\/bevoelkerung-und-soziales\/gesundheit\/krebserkrankungen. Accessed 6 Feb 2023."},{"key":"2209_CR2","unstructured":"Statistik Austria. Krebserkrankungen in \u00d6sterreich. https:\/\/www.statistik.at\/fileadmin\/publications\/Krebserkrankungen_2022.pdf. Accessed 6 Feb 2023."},{"issue":"2","key":"2209_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1053\/j.gastro.2011.10.033","volume":"142","author":"RM Winkels","year":"2012","unstructured":"Winkels\u00a0RM, Botma\u00a0A, Van Duijnhoven\u00a0FJ, Nagengast\u00a0FM, Kleibeuker\u00a0JH, Vasen\u00a0HF, et\u00a0al. Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome. Gastroenterology. 2012;142(2):241\u20137.","journal-title":"Gastroenterology"},{"key":"2209_CR4","unstructured":"\u00d6sterreichische Gesellschaft f\u00fcr Gastroenterologie und Hepatologie. Leitlinie Qualit\u00e4tsgesicherte Vorsorgekoloskopie. http:\/\/www.oeggh.at\/fachwissen\/leitlinien\/darm.html. Accessed 6 Feb 2023."},{"key":"2209_CR5","doi-asserted-by":"publisher","DOI":"10.17226\/13058","volume-title":"Clinical practice guidelines we Can trust","author":"Institute of Medicine","year":"2011","unstructured":"Institute of Medicine. Clinical practice guidelines we Can trust. Washington, DC: The National Academies Press; 2011. https:\/\/doi.org\/10.17226\/13058."},{"key":"2209_CR6","unstructured":"U.S. Preventive Services Task Force. Procedure Manual. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/sites\/default\/files\/inline-files\/procedure-manual-2022.pdf. Accessed 23 Jan 2023."},{"key":"2209_CR7","unstructured":"Bundesministerium f\u00fcr Soziales, Gesundheit, Pflege und Konsumentenschutz. Evidenzgrundlagen und Empfehlungen zur Einf\u00fchrung eines organisierten Darmkrebs-Screening-Programms in \u00d6sterreich. https:\/\/jasmin.goeg.at\/2298\/1\/BMSGPK_Entscheidungsgrundlage_Darmkrebs-Screening_bf.pdf. Accessed 23 Jan 2023."},{"key":"2209_CR8","unstructured":"Sch\u00fcnemann H, Brozek J, Guyatt G, Oxman A. The GRADE handbook. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html#h.9rdbelsnu4iy. Accessed 23 Jan 2023."},{"issue":"4","key":"2209_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem\u00a0H, Helfand\u00a0M, Sch\u00fcnemann\u00a0HJ, Oxman\u00a0AD, Kunz\u00a0R, Brozek\u00a0J, et\u00a0al. GRADE guidelines: 3. Rating the quality of evidence. J\u00a0Clin Epidemiol. 2011;64(4):401\u20136.","journal-title":"J Clin Epidemiol"},{"key":"2209_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jclinepi.2020.09.018","volume":"129","author":"JL Brozek","year":"2021","unstructured":"Brozek\u00a0JL, Canelo-Aybar\u00a0C, Akl\u00a0EA, Bowen\u00a0JM, Bucher\u00a0J, Chiu\u00a0WA, et al. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence\u2014An overview in the context of health decision-making. J\u00a0Clin Epidemiol. 2021;129:138\u201350.","journal-title":"J Clin Epidemiol"},{"key":"2209_CR11","volume-title":"Preventive services task force evidence syntheses, formerly systematic evidence reviews. Screening for colorectal cancer: an evidence update for the US preventive services task force","author":"JS Lin","year":"2021","unstructured":"Lin\u00a0JS, Perdue\u00a0LA, Henrikson\u00a0NB, Bean\u00a0SI, Blasi\u00a0PRUS. Preventive services task force evidence syntheses, formerly systematic evidence reviews. Screening for colorectal cancer: an evidence update for the US preventive services task force. Rockville: Agency for Healthcare Research and Quality; 2021."},{"issue":"18","key":"2209_CR12","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1002\/cncr.29462","volume":"121","author":"HM Chiu","year":"2015","unstructured":"Chiu\u00a0HM, Chen\u00a0SL, Yen\u00a0AM, Chiu\u00a0SY, Fann\u00a0JC, Lee\u00a0YC, et\u00a0al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer. 2015;121(18):3221\u20139.","journal-title":"Cancer"},{"issue":"1","key":"2209_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/gut.2009.177089","volume":"59","author":"L Hol","year":"2010","unstructured":"Hol\u00a0L, van Leerdam\u00a0ME, van Ballegooijen\u00a0M, van Vuuren\u00a0AJ, van Dekken\u00a0H, Reijerink\u00a0JC, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(1):62\u20138.","journal-title":"Gut"},{"issue":"1","key":"2209_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.gastro.2008.03.040","volume":"135","author":"LG van Rossum","year":"2008","unstructured":"van Rossum\u00a0LG, van Rijn\u00a0AF, Laheij\u00a0RJ, van Oijen\u00a0MG, Fockens\u00a0P, van Krieken\u00a0HH, et\u00a0al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a\u00a0screening population. Gastroenterology. 2008;135(1):82\u201390.","journal-title":"Gastroenterology"},{"issue":"16","key":"2209_CR15","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.ejca.2012.04.007","volume":"48","author":"J Faivre","year":"2012","unstructured":"Faivre\u00a0J, Dancourt\u00a0V, Denis\u00a0B, Dorval\u00a0E, Piette\u00a0C, Perrin\u00a0P, et\u00a0al. Comparison between a\u00a0guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer. Eur J Cancer. 2012;48(16):2969\u201376.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2209_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12876-019-1121-y","volume":"19","author":"B Jahn","year":"2019","unstructured":"Jahn\u00a0B, Sroczynski\u00a0G, Bundo\u00a0M, M\u00fchlberger\u00a0N, Puntscher\u00a0S, Todorovic\u00a0J, et\u00a0al. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria. BMC Gastroenterol. 2019;19(1):209.","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"2209_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa1301969","volume":"369","author":"R Nishihara","year":"2013","unstructured":"Nishihara\u00a0R, Wu\u00a0K, Lochhead\u00a0P, Morikawa\u00a0T, Liao\u00a0X, Qian\u00a0ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N\u00a0Engl J Med. 2013;369(12):1095\u2013105.","journal-title":"N Engl J Med"},{"issue":"1","key":"2209_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7326\/M16-0758","volume":"166","author":"X Garc\u00eda-Alb\u00e9niz","year":"2017","unstructured":"Garc\u00eda-Alb\u00e9niz\u00a0X, Hsu\u00a0J, Bretthauer\u00a0M, Hern\u00e1n\u00a0MA. Effectiveness of screening Colonoscopy to prevent colorectal cancer among medicare beneficiaries aged 70 to 79 years: a prospective observational study. Ann Intern Med. 2017;166(1):18\u201326.","journal-title":"Ann Intern Med"},{"issue":"17","key":"2209_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2208375","volume":"387","author":"M Bretthauer","year":"2022","unstructured":"Bretthauer\u00a0M, L\u00f8berg\u00a0M, Wieszczy\u00a0P, Kalager\u00a0M, Emilsson\u00a0L, Garborg\u00a0K, et\u00a0al. Effect of Colonoscopy screening on risks of colorectal cancer and related death. N\u00a0Engl J Med. 2022;387(17):1547\u201356.","journal-title":"N Engl J Med"},{"issue":"3","key":"2209_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cgh.2019.08.015","volume":"18","author":"EJ Grobbee","year":"2020","unstructured":"Grobbee\u00a0EJ, van der Vlugt\u00a0M, van Vuuren\u00a0AJ, Stroobants\u00a0AK, Mallant-Hent\u00a0RC, Lansdorp-Vogelaar\u00a0I, et al. Diagnostic yield of one-time Colonoscopy vs one-time flexible Sigmoidoscopy vs multiple rounds of mailed fecal Immunohistochemical tests in colorectal cancer screening. Clin Gastroenterol Hepatol. 2020;18(3):667\u2013675.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2209_CR21","doi-asserted-by":"publisher","unstructured":"Sali L, Mascalchi M, Falchini M, Ventura L, Carozzi F, Castiglione G, et al. Reduced and full-preparation CT Colonography, fecal immunochemical test, and Colonoscopy for population screening of colorectal cancer: a randomized trial. J\u00a0Natl Cancer Inst. 2016;108(2), February 2016, djv319. https:\/\/doi.org\/10.1093\/jnci\/djv319.","DOI":"10.1093\/jnci\/djv319"},{"issue":"5","key":"2209_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/jnci\/dji050","volume":"97","author":"N Segnan","year":"2005","unstructured":"Segnan\u00a0N, Senore\u00a0C, Andreoni\u00a0B, Arrigoni\u00a0A, Bisanti\u00a0L, Cardelli\u00a0A, et\u00a0al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J\u00a0Natl Cancer Inst. 2005;97(5):347\u201357.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2209_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa1108895","volume":"366","author":"E Quintero","year":"2012","unstructured":"Quintero\u00a0E, Castells\u00a0A, Bujanda\u00a0L, Cubiella\u00a0J, Salas\u00a0D, Lanas \u00c1, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N\u00a0Engl J Med. 2012;366(8):697\u2013706.","journal-title":"N Engl J Med"},{"key":"2209_CR24","volume-title":"U.S. Preventive services task force evidence syntheses, formerly systematic evidence reviews. Colorectal cancer screening: an updated decision analysis for the US preventive services task force","author":"AB Knudsen","year":"2021","unstructured":"Knudsen\u00a0AB, Rutter\u00a0CM, Peterse\u00a0EFP, Lietz\u00a0AP, Seguin\u00a0CL, Meester\u00a0RGS, et\u00a0al. U.S. Preventive services task force evidence syntheses, formerly systematic evidence reviews. Colorectal cancer screening: an updated decision analysis for the US preventive services task force. Rockville: Agency for Healthcare Research and Quality; 2021."},{"key":"2209_CR25","unstructured":"Copenhagen: WHO Regional Office for Europe. Screening programmes: a\u00a0short guide. Increase effectiveness, maximize benefits and minimize harm. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/330829\/9789289054782-eng.pdf. Accessed 6 Feb 2023."},{"key":"2209_CR26","unstructured":"Wilson J, Jungner G, World Health Organization. Principles and practice of screening for disease. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/37650\/WHO_PHP_34.pdf?sequence=17&isAllowed=y. Accessed 6 Feb 2023."},{"key":"2209_CR27","first-page":"143","volume-title":"When should decision-analytic modeling be used in the economic evaluation of health care?","author":"U Siebert","year":"2003","unstructured":"Siebert\u00a0U. When should decision-analytic modeling be used in the economic evaluation of health care? Springer; 2003. pp. 143\u201350."}],"updated-by":[{"DOI":"10.1007\/s00508-023-02251-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000}}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02209-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02209-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02209-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T15:09:33Z","timestamp":1694531373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02209-0"}},"subtitle":["A\u00a0recommendation statement of the Austrian National Committee for Cancer Screening"],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":27,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02209-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00508-023-02251-y","asserted-by":"object"}]},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"15 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00508-023-02251-y","URL":"https:\/\/doi.org\/10.1007\/s00508-023-02251-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.\u00a0Gartlehner, E.\u00a0Schernhammer, S.F.\u00a0Lax, H.\u00a0Bachler, H.\u00a0Titzer, M.\u00a0Kletecka-Pulker and H.\u00a0Turnher declare that they have no competing interests. M.\u00a0Preusser has received honoraria for lectures, consultation, or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Servier. U.\u00a0Siebert declares that he is a\u00a0member of the Oncology Advisory Council of the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection, a\u00a0member of the European Commission Initiative on Colorectal Cancer (ECICC) Expert Pool, and Co-Chair of the international SMDM Modeling Good Research Practices Task Force.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}